COVID-19: The ROX index for predicting HFNC failure

6 Apr 2020

Apple Podcasts or Listen Here

We are bringing you near-daily updates on COVID-19. There is a firehose of information and most of us are too busy to read and digest it all. Note: If you are listening to these more than a few days in the future, please beware that information may have changed and check subsequent episodes.

Today we are joined by Dr. Rory Spiegel of EMNerd to discuss the ROX index which has been proposed as a means of predicting who might fail high flow nasal cannula, and has been proposed as a part of some pathways for COVID-19 respiratory management

Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016;35:200-5.
Roca O, Caralt B, Messika J, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019;199(11):1368-1376

Check out Brief19 for COVID-19 related policy updates